Making the ethical oversight of all clinical trials fit for purpose

JAMA

2024-10-19

(Press-News.org) About The Study: This article examines ethical oversight of clinical research in the U.S. and offers practical recommendations that are consistent with current regulations and that could help to make research oversight better fit for purpose for different types of studies.

Corresponding Author: To contact the corresponding author, Nancy E. Kass, ScD, email nkass@jhu.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2024.0269)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0269?guestAccessKey=0e843b02-3531-4628-92b6-b4db8135bf69&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101924

END

ELSE PRESS RELEASES FROM THIS DATE:

Long-term low-dose antiviral treatment benefits patients with eye disease and pain from shingles

2024-10-19

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to new research presented October 19 at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago. Shingles occurs when the varicella-zoster virus, which causes chickenpox in children, lies dormant for decades in nerve cells and then starts multiplying again for reasons unknown. It commonly affects people 50 and older, and ...

Long-term antiviral use is key to ocular shingles treatment

2024-10-19

Taking an antiviral medication for a year may prevent vision damage associated with shingles that affects the eye, according to new research led by faculty from the Perelman School of Medicine at the University of Pennsylvania and the NYU Grossman School of Medicine at NYU Langone Health. “Up until now, there has been no proven long-term treatment for new, worsening, or repeated episodes of this disease, so the results of this study provide convincing evidence for using long-term, low-dose antiviral treatment,” said Bennie Jeng, MD, chair of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania ...

American Society of Anesthesiologists honors Mary Dale Peterson, M.D., MSHCA, FACHE, FASA, with its Distinguished Service Award

2024-10-19

PHILADELPHIA — The American Society of Anesthesiologists (ASA) today presented Mary Dale Peterson, M.D., MSHCA, FACHE, FASA, with its 2023 Distinguished Service Award in recognition of her enduring contributions to advancing patient-centered, physician-led health care. Her dedicated service to the specialty and ASA includes her leadership as ASA president during the first year of the COVID-19 pandemic. The award is the highest honor ASA bestows and is presented annually to a member who has transformed the specialty of anesthesiology. Nationally recognized for her role in guiding health plans and hospitals, Dr. Peterson currently serves ...

Innovation south facility opens in UT Research Park at Cherokee farm

2024-10-18

The University of Tennessee, Knoxville’s Fibers and Composites Manufacturing Facility has a new home and IACMI – The Composites Institute has new headquarters with the dedication of Innovation South. Innovation South is an 85,000-square-foot multiuse facility in UT’s Research Park at Cherokee Farm, located just off Alcoa Highway across the Tennessee River from the flagship university’s main campus. Developed and owned by Partners Development, the building includes a 40,000-square-foot ...

Photonic computing harnesses electromagnetic waves

2024-10-18

In the fields of physics, mathematics, and engineering, partial differential equations (PDEs) are essential for modeling various phenomena, from heat diffusion to particle motion and wave propagation. While some PDEs can be solved analytically, many require numerical methods, which can be time-consuming and computationally intensive. To address these challenges, scientists have been exploring alternative computing paradigms, including photonic computing. Photonic computing leverages light–matter interactions to perform ...

Loss of ‘nitrogen fixers’ threatens biodiversity, ecosystems

2024-10-18

STARKVILLE, Miss.—Mississippi State University is part of a European-American collaboration studying how human activities, like fertilizer use and polluting, are impacting nitrogen-fixing plants which are crucial for maintaining healthy ecosystems by adding nitrogen to the soil. MSU Assistant Professor Ryan A. Folk of the Department of Biological Sciences co-authored a study published today [Oct. 18] in Science Advances, showing that increased nitrogen deposition from human activity is reducing the diversity and evolutionary distinctiveness of nitrogen-fixing plants. Lead author Pablo Moreno García, ...

UH Energy Transition Institute launches radio show and online webinars focused on addressing grand challenges in energy

2024-10-18

HOUSTON, Oct. 18, 2024 –The University of Houston Energy Transition Institute is launching two educational series focused on exploring the unfolding energy transition and addressing the grand challenges in energy. Starting October 21, "Driving the Energy Transition," will air on Houston Public Media’s KUHF News 88.7 with new episodes launching every two weeks on Mondays. The following day, October 22, the Energy Transition Webinar series will begin, running biweekly on ...

UVA professor tackles graph mining challenges with new algorithm

2024-10-18

University of Virginia School of Engineering and Applied Science professor Nikolaos Sidiropoulos has introduced a breakthrough in graph mining with the development of a new computational algorithm. Graph mining, a method of analyzing networks like social media connections or biological systems, helps researchers discover meaningful patterns in how different elements interact. The new algorithm addresses the long-standing challenge of finding tightly connected clusters, known as triangle-dense subgraphs, within large networks — a problem that is critical in fields such as fraud detection, computational biology and data ...

Announcing the new editor-in-chief of ASSAY and Drug Development Technologies

2024-10-18

New Rochelle, NY, October 17, 2025—Mary Ann Liebert, Inc., is pleased that Wai Hong (Kevin) Lo, PhD, has been appointed the new Editor-in-Chief of the journal ASSAY and Drug Development Technologies. Dr. Lo is replacing Bruce Melancon, PhD as Editor-in-Chief. ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This peer-reviewed journal features original papers application-oriented technology reviews, topical issues on ...

Finding could help turn trees into affordable, greener industrial chemicals

2024-10-18

EMBARGOED FOR RELEASE UNTIL 2 P.M. EDT ON FRIDAY, OCT. 18 Trees are the most abundant natural resource living on Earth’s land masses, and North Carolina State University scientists and engineers are making headway in finding ways to use them as sustainable, environmentally benign alternatives to producing industrial chemicals from petroleum. Lignin, a polymer that makes trees rigid and resistant to degradation, has proven problematic. Now those NC State researchers know why: They’ve identified the ...

The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Con

Making the ethical oversight of all clinical trials fit for purpose

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: